| The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain B Costa, AE Trovato, F Comelli, G Giagnoni, M Colleoni European journal of pharmacology 556 (1-3), 75-83, 2007 | 447 | 2007 |
| CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation I Zanoni, R Ostuni, G Capuano, M Collini, M Caccia, AE Ronchi, ... Nature 460 (7252), 264-268, 2009 | 391 | 2009 |
| The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and … B Costa, F Comelli, I Bettoni, M Colleoni, G Giagnoni Pain 139 (3), 541-550, 2008 | 372 | 2008 |
| Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation B Costa, G Giagnoni, C Franke, AE Trovato, M Colleoni British journal of pharmacology 143 (2), 247-250, 2004 | 347 | 2004 |
| Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw B Costa, M Colleoni, S Conti, D Parolaro, C Franke, AE Trovato, ... Naunyn-Schmiedeberg's archives of pharmacology 369, 294-299, 2004 | 303 | 2004 |
| The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells P Massi, A Vaccani, S Bianchessi, B Costa, P Macchi, D Parolaro Cellular and Molecular Life Sciences CMLS 63, 2057-2066, 2006 | 264 | 2006 |
| Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice I Bettoni, F Comelli, C Rossini, F Granucci, G Giagnoni, F Peri, B Costa Glia 56 (12), 1312-1319, 2008 | 255 | 2008 |
| Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat S Conti, B Costa, M Colleoni, D Parolaro, G Giagnoni British journal of pharmacology 135 (1), 181-187, 2002 | 238 | 2002 |
| Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement … S Holt, F Comelli, B Costa, CJ Fowler British journal of pharmacology 146 (3), 467-476, 2005 | 190 | 2005 |
| Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo‐oxygenase systems B Costa, S Conti, G Giagnoni, M Colleoni British journal of pharmacology 137 (4), 413-420, 2002 | 185 | 2002 |
| The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1β, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after … C Martucci, AE Trovato, B Costa, E Borsani, S Franchi, V Magnaghi, ... Pain® 137 (1), 81-95, 2008 | 177 | 2008 |
| The plant cannabinoid Δ9‐tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice D Bolognini, B Costa, S Maione, F Comelli, P Marini, V Di Marzo, ... British journal of pharmacology 160 (3), 677-687, 2010 | 169 | 2010 |
| Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved F Comelli, G Giagnoni, I Bettoni, M Colleoni, B Costa Phytotherapy research 22 (8), 1017-1024, 2008 | 146 | 2008 |
| Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve B Costa, AE Trovato, M Colleoni, G Giagnoni, E Zarini, T Croci Pain 116 (1-2), 52-61, 2005 | 118 | 2005 |
| AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain B Costa, D Siniscalco, AE Trovato, F Comelli, ML Sotgiu, M Colleoni, ... British journal of pharmacology 148 (7), 1022-1032, 2006 | 117 | 2006 |
| On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC) B Costa Chemistry & biodiversity 4 (8), 1664-1677, 2007 | 111 | 2007 |
| Endocannabinoids: a unique opportunity to develop multitarget analgesics S Maione, B Costa, V Di Marzo PAIN® 154, S87-S93, 2013 | 108 | 2013 |
| The inhibition of monoacylglycerol lipase by URB602 showed an anti‐inflammatory and anti‐nociceptive effect in a murine model of acute inflammation F Comelli, G Giagnoni, I Bettoni, M Colleoni, B Costa British journal of pharmacology 152 (5), 787-794, 2007 | 107 | 2007 |
| Repeated treatment with the synthetic cannabinoid WIN 55,212‐2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain B Costa, M Colleoni, S Conti, AE Trovato, M Bianchi, ML Sotgiu, ... British journal of pharmacology 141 (1), 4-8, 2004 | 107 | 2004 |
| Beneficial effects of a Cannabis sativa extract treatment on diabetes‐induced neuropathy and oxidative stress F Comelli, I Bettoni, M Colleoni, G Giagnoni, B Costa Phytotherapy research 23 (12), 1678-1684, 2009 | 104 | 2009 |
